A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis

Atopic dermatitis (AD) is a chronic inflammatory skin disease with pruritus, characterized by recurrent eczema with exacerbations and remissions. AD impairs patients’ QOL and places a heavy burden on patients. Recently, dupilumab, an anti–IL-4Rα antibody, was approved for the treatment of patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamata, Masahiro, Tada, Yayoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659403/
https://www.ncbi.nlm.nih.gov/pubmed/34909737
http://dx.doi.org/10.1016/j.xjidi.2021.100042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659403/
https://www.ncbi.nlm.nih.gov/pubmed/34909737
http://dx.doi.org/10.1016/j.xjidi.2021.100042

Ejemplares similares